FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308790718> ?p ?o ?g. }

• W4308790718 endingPage "25" @default.
• W4308790718 startingPage "1" @default.
• W4308790718 abstract "To investigate the expression of protein disulfide isomerase A3 (PDIA3/ERP57) in cervical cancer and its clinical prognostic significance as well as its function and possible action mechanism in the progression of cervical cancer. Based on TIMER2.0 database, the human protein map (Human Protein Atlas) was used to determine the expression level of PDIA3 protein for the analysis of PDIA3 expression in 39 The Cancer Genome Atlas (TCGA) tumors. The PDIA3 expression in cervical cancer tissues in the TCGA and Genotype-Tissue Expression databases was further verified based on the GEPIA2 database to analyze the relationship between the PDIA3 expression and the pathological stage of cervical cancer patients. Immunohistochemistry was used to detect the PDIA3 expression in cervical cancer tissue microarray, including 111 cancer tissue samples and 24 adjacent cancer tissue samples, and the relationship between PDIA3 protein expression and clinical characteristics of patients with cervical cancer was analyzed. The Kaplan-Meier method and log-rank test were used for survival analysis. Based on the cBioPortal database, the Spearman's and Pearson's methods were used to analyze the correlation between PDIA3 expression and DNA methylation. The correlation between PDIA3 expression and the infiltration levels of each immune cell in cervical cancer was evaluated. The STRING was used to construct protein interaction network. Based on LinkedOmics database, the Spearman's method was used to analyze the co-expressed genes of PDIA3 in TCGA cervical cancer. The gene ontology functional enrichment analysis was performed on Top 50 differentially co-expressed genes based on DAVID database. The PDIA3 expression in cervical cancer tissues was significantly higher than that in normal tissues, which (F = 2.74, PR (>F) = 0.0436) was significantly increased with the progression of tumor stage, and PDIA3 showed strong immunoreactivity in cervical cancer tissues. In cervical cancer patients, overall survival (P = 0.014), disease-specific survival (P = 0.013), disease-free interval (P = 0.023), and progression-free interval (P = 0.001) in those with high expression of PDIA3 were significantly lower than those with low expression, suggesting that high expression of PDIA3 was associated with poor prognosis. In cervical cancer, high expression of PDIA3 was associated with DNA methylation and negatively correlated with B cell memory (r = -0.132, P = 0.021), T cell regulatory (r = -0.127, P = 0.026), monocytes (r = -0.204, P = 0), and macrophages M2 (r = -0.142, P = 0.013), whereas positively correlated with levels of NK cell activated (r = 0.162, P = 0.005) and mast cells activated (r = 0.119, P = 0.037). The genes positively correlated with PDIA3 expression included HSPA5 and PPIB, which were mainly enriched in biological processes, such as endoplasmic reticulum (ER) protein folding and ER stress response. PDIA3 can be used as a marker of poor prognosis of cervical cancer. The expression level of PDIA3 is closely related to the survival and prognosis of cervical cancer patients, DNA methylation, and immune cell infiltration." @default.
• W4308790718 created "2022-11-15" @default.
• W4308790718 creator A5017947172 @default.
• W4308790718 creator A5039832836 @default.
• W4308790718 creator A5068795845 @default.
• W4308790718 creator A5069272786 @default.
• W4308790718 creator A5075222441 @default.
• W4308790718 creator A5081969040 @default.
• W4308790718 date "2022-11-11" @default.
• W4308790718 modified "2023-09-26" @default.
• W4308790718 title "Expression and Prognostic Significance of PDIA3 in Cervical Cancer" @default.
• W4308790718 cites W1591732376 @default.
• W4308790718 cites W1614119979 @default.
• W4308790718 cites W1970425754 @default.
• W4308790718 cites W1987762716 @default.
• W4308790718 cites W1993106222 @default.
• W4308790718 cites W2000084288 @default.
• W4308790718 cites W2085536599 @default.
• W4308790718 cites W2095145356 @default.
• W4308790718 cites W2096664100 @default.
• W4308790718 cites W2103680668 @default.
• W4308790718 cites W2140968674 @default.
• W4308790718 cites W2144974591 @default.
• W4308790718 cites W2151574490 @default.
• W4308790718 cites W2401941078 @default.
• W4308790718 cites W2511694145 @default.
• W4308790718 cites W2534500708 @default.
• W4308790718 cites W2535779447 @default.
• W4308790718 cites W2592965279 @default.
• W4308790718 cites W2735892656 @default.
• W4308790718 cites W2741092632 @default.
• W4308790718 cites W2772026032 @default.
• W4308790718 cites W2803214389 @default.
• W4308790718 cites W2803332775 @default.
• W4308790718 cites W2909503380 @default.
• W4308790718 cites W2914095913 @default.
• W4308790718 cites W2990224216 @default.
• W4308790718 cites W3022742009 @default.
• W4308790718 cites W3042493843 @default.
• W4308790718 cites W3095068999 @default.
• W4308790718 cites W3128646645 @default.
• W4308790718 cites W3137846970 @default.
• W4308790718 cites W3138912681 @default.
• W4308790718 cites W3157122263 @default.
• W4308790718 cites W3158908584 @default.
• W4308790718 cites W3196850190 @default.
• W4308790718 cites W4200031928 @default.
• W4308790718 cites W4200204470 @default.
• W4308790718 cites W4206062925 @default.
• W4308790718 cites W4206690268 @default.
• W4308790718 cites W4221038666 @default.
• W4308790718 doi "https://doi.org/10.1155/2022/4382645" @default.
• W4308790718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36406049" @default.
• W4308790718 hasPublicationYear "2022" @default.
• W4308790718 type Work @default.
• W4308790718 citedByCount "1" @default.
• W4308790718 countsByYear W43087907182023 @default.
• W4308790718 crossrefType "journal-article" @default.
• W4308790718 hasAuthorship W4308790718A5017947172 @default.
• W4308790718 hasAuthorship W4308790718A5039832836 @default.
• W4308790718 hasAuthorship W4308790718A5068795845 @default.
• W4308790718 hasAuthorship W4308790718A5069272786 @default.
• W4308790718 hasAuthorship W4308790718A5075222441 @default.
• W4308790718 hasAuthorship W4308790718A5081969040 @default.
• W4308790718 hasBestOaLocation W43087907181 @default.
• W4308790718 hasConcept C104317684 @default.
• W4308790718 hasConcept C121608353 @default.
• W4308790718 hasConcept C126322002 @default.
• W4308790718 hasConcept C142724271 @default.
• W4308790718 hasConcept C143998085 @default.
• W4308790718 hasConcept C150194340 @default.
• W4308790718 hasConcept C158163496 @default.
• W4308790718 hasConcept C204232928 @default.
• W4308790718 hasConcept C2778220009 @default.
• W4308790718 hasConcept C41008148 @default.
• W4308790718 hasConcept C55493867 @default.
• W4308790718 hasConcept C6856738 @default.
• W4308790718 hasConcept C71924100 @default.
• W4308790718 hasConcept C77088390 @default.
• W4308790718 hasConcept C86803240 @default.
• W4308790718 hasConceptScore W4308790718C104317684 @default.
• W4308790718 hasConceptScore W4308790718C121608353 @default.
• W4308790718 hasConceptScore W4308790718C126322002 @default.
• W4308790718 hasConceptScore W4308790718C142724271 @default.
• W4308790718 hasConceptScore W4308790718C143998085 @default.
• W4308790718 hasConceptScore W4308790718C150194340 @default.
• W4308790718 hasConceptScore W4308790718C158163496 @default.
• W4308790718 hasConceptScore W4308790718C204232928 @default.
• W4308790718 hasConceptScore W4308790718C2778220009 @default.
• W4308790718 hasConceptScore W4308790718C41008148 @default.
• W4308790718 hasConceptScore W4308790718C55493867 @default.
• W4308790718 hasConceptScore W4308790718C6856738 @default.
• W4308790718 hasConceptScore W4308790718C71924100 @default.
• W4308790718 hasConceptScore W4308790718C77088390 @default.
• W4308790718 hasConceptScore W4308790718C86803240 @default.
• W4308790718 hasFunder F4320316319 @default.
• W4308790718 hasLocation W43087907181 @default.
• W4308790718 hasLocation W43087907182 @default.

• next